Total submissions: 2
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Gene |
RCV000523482 | SCV000617548 | likely pathogenic | not provided | 2017-09-05 | criteria provided, single submitter | clinical testing | The K709E variant has been published previsouly in association with Hyper-IgE syndrome (de Beaucoudrey et al., 2008; Chandesris et al., 2012). The variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). K709E is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position within the transactivation domain that is conserved across species (Chandesris et al., 2012). In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. Functional studies are also conflicting for this variant. One stimulated phosphorylation study of transfected COS cells demonstrated K709E was activated at a similar rate to wild type (Inoue et al., 1997). However, another study using immortalized patient cells showed K709E resulted in reduced activation of STAT3 and subsequently lower levels of activated STAT3 within the nucleus (Chandesris et al., 2012). In summary, this variant is likely pathogenic; however, the possibility that it is benign cannot be excluded. |
| Labcorp Genetics |
RCV005222989 | SCV005863600 | likely pathogenic | Hyper-IgE recurrent infection syndrome 1, autosomal dominant; STAT3 gain of function | 2024-07-30 | criteria provided, single submitter | clinical testing | This sequence change replaces lysine, which is basic and polar, with glutamic acid, which is acidic and polar, at codon 709 of the STAT3 protein (p.Lys709Glu). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with hyper IgE syndrome (PMID: 22084479, 22751495, 34390440; Invitae). ClinVar contains an entry for this variant (Variation ID: 449411). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. |